Saturday, February 23, 2008

Daptomycin: a new treatment for insidious infections due to gram-positive pathogens

Daptomycin: a new treatment for insidious infections due to gram-positive pathogens

February 2008

Cottagnoud P.

Department of Internal Medicine, Inselspital, Bern, Switzerland.
Philippe.Cottagnoud@insel.ch.

Daptomycin, a new lipopeptide antibiotic, is highly bactericidal against the majority of Grampositive human pathogens, including methicillinresistant (MRSA) and vancomycin-resistant enterococci. Its mechanism of action is unique resulting in the destruction of the membrane potential without lysing the cell wall. The mechanism of action of daptomycin, its antibacterial spectrum, the development of resistance and pre- and clinical studies are discussed in this review.


PMID: 18293118 [PubMed - in process]